Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
07/2001
07/10/2001US6258360 Benzoate conjugates; antitumor agents
07/05/2001US20010006801 Active ribozyme
07/04/2001EP1113020A2 Nucleosides and oligonucleotides containing boron clusters
07/04/2001EP1112281A1 Pteridine nucleotide analogs
07/04/2001EP1112066A2 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor
07/04/2001EP1060264A4 Dideoxy dye terminators
07/04/2001CN1302304A AZT derivatives exhibiting spermicidal and anti-viral activity
07/03/2001US6255476 Reacting a labelled solid support of given formula to remove an acid cleavable protecting group, adding a 5'-phosphoramidite, 3'-protected nucleoside and an activator to from a bond
07/03/2001US6255475 Chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation
07/03/2001US6255463 Preparing an avermectin compound of given formula useful as antiparasitic agent from an avermectin b2 compound, a fermentation derived avermectin product
07/03/2001US6255292 Increasing cellular contractions
07/03/2001US6255083 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis
07/03/2001US6254526 Hearing aid having hard mounting plate and soft body bonded thereto
06/2001
06/28/2001WO2001046212A1 Treatment of viral infections using levovirin?tm¿
06/28/2001WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer
06/28/2001WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
06/28/2001WO2001045691A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists
06/28/2001WO2001045509A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
06/28/2001WO2000078776A3 Thiophene a2a receptor agonists
06/28/2001WO2000075142A3 Dna methyltransferase inhibitors
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/28/2001CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
06/28/2001CA2395108A1 Method of treating gastrointestinal tract disease with purinergic receptor agonists
06/28/2001CA2384326A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
06/28/2001CA2384110A1 Treatment of viral infections using levovirintm
06/27/2001EP1110554A1 Medicinal compositions for treating eye diseases
06/27/2001EP1109825A1 Improved process for the synthesis of oligonucleotides incorporating 2-aminoadenosine
06/27/2001EP1109818A1 Phosphoepoxides, method for making same and uses
06/27/2001EP1109817A1 Phosphohalohydrins, method for making same and uses
06/27/2001EP1109785A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
06/27/2001CN1301168A Therapeutic dinucleotide and derivatives
06/26/2001US6252061 Process for the production of 2-halo-6-aminopurine derivatives
06/26/2001US6252060 Antiviral liponucleosides: treatment of hepatitis B
06/26/2001US6251858 Derivatives of glycosylamine in which the oligosides are fixed on at least one molecule, matrix or particle
06/26/2001US6251666 Ribozyme with at least one l-nucleotide substitution; nuclease resistance
06/26/2001US6251639 Methods and compositions for linear isothermal amplification of polynucleotide sequences, using a RNA-DNA composite primer
06/21/2001WO2001044265A1 Treatment of mental conditions including depression
06/21/2001WO2001043731A2 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
06/21/2001WO2000006771A3 Nucleic acid labeling compounds
06/21/2001CA2390821A1 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
06/20/2001EP1108724A2 Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
06/20/2001EP0920438B1 N6 heterocyclic substituted adenosine derivatives
06/19/2001US6248884 Particularly well suited for use in automated fluorescence-based dna sequencing systems using an excitation light source having a wavelength greater than about 630 nm, e.g., a helium-neon gas laser or a solid state diode laser.
06/19/2001US6248878 Nucleoside analogs
06/19/2001US6248568 Hybridizing oligonucleotide primer to template nucleic acid and adding primer extension reagents including a nucleoside compound of defined structure; nucleotides for use as chain terminating substrates in fluorescence based sequencing
06/14/2001WO2001042265A2 N6 heterocyclic 8-modified adenosine derivatives
06/14/2001WO2001005773A8 Conjugates of sodium channel blockers and methods of using the same
06/14/2001US20010003744 Therapeutic compounds
06/13/2001EP1105403A1 3'-desoxypentopyranosyl nucleic acid, its production and its use
06/13/2001CN1298880A Cyanoribofuranoside compound and its preparing process
06/12/2001US6245938 4-pentenoyl groups for derivatization and protection of amino acids
06/12/2001US6245750 Thymidine phosphoramide derivative; antiproliferative, anticarcinogenic agents; enzyme inhibitors;
06/12/2001US6245749 Nucleosides with anti-hepatitis B virus activity
06/12/2001US6245506 Immobilizing biopolymer on solid support in reaction vessel, mixing with ion dependent enzyme and pressure sensitive buffer, altering pressure in the vessel to allow reaction to occur, determining identity of dissociated terminal monomer
06/12/2001CA2046857C Morpholinyl derivatives of doxorubicin and process for their preparation
06/07/2001WO2001040799A2 Method of identifying partial adenosine a1 receptor agonists and their use in the treatment of arrhythmias
06/07/2001WO2001040515A1 Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages
06/07/2001WO2001040246A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
06/07/2001WO2001040245A1 N6 heterocyclic 5' modified adenosine derivatives
06/07/2001WO2001040244A1 N6 heterocyclic 5' modified adenosine derivatives
06/07/2001WO2001040243A2 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
06/07/2001WO2001039724A2 Phosphonate compounds
06/07/2001WO2001012642A3 Nucleoside derivatives and a method for producing same
06/07/2001WO2000030629A3 Method of promoting cervical and vaginal secretions
06/07/2001WO1999063940A3 INHIBITORS OF H+K+-ATPase
06/07/2001CA2747954A1 Phosphonate compounds
06/06/2001EP1104436A2 Ss-l-2'-deoxy-nucleosides for the treatment of hepatitis b virus
06/05/2001US6242592 Process for the preparation of 2′-O-alkyl-guanosine, cytidine, and uridine phosphoramidites
06/05/2001US6242589 Phosphorothioate oligonucleotides having modified internucleoside linkages
06/05/2001US6242429 Antiviral ara-a derivatives having resistance to metabolism by adenosinedeaminase
06/05/2001US6242428 Nucleosides and nucleoside dimers containing an l-sugar in at least one of the nucleosides
06/05/2001US6242193 Apparatus for determining base sequence of nucleic acid
05/2001
05/31/2001WO2001037845A1 Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines
05/31/2001CA2392369A1 Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines
05/30/2001EP1103559A1 Autoimmune nucleosides
05/30/2001EP1102783A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom
05/30/2001EP1102782A1 Structural analogs of amine bases and nucleosides
05/30/2001EP1102781A1 New cofactors for methyltransferases
05/30/2001CN1297350A Agents for relieving side effects
05/30/2001CN1066456C Oligonucleotides having 2'-ether groups
05/29/2001US6239272 Oligonucleotide having one or more modified nucleotides of defined structure; antisense agents; ribozymes
05/29/2001US6239265 Oligonucleotides having chiral phosphorus linkages
05/29/2001US6239159 Nucleoside analogues
05/29/2001US6238867 Compositions, methods and kits for identifying naturally occurring RNA sequences having affinity for RNA-binding proteins
05/29/2001CA2156717C Solution and solid-phase formation of glycosidic linkages
05/25/2001WO2001036438A1 Novel ribose compounds
05/25/2001WO2001036435A1 Glucofuranoses
05/25/2001WO2001036416A1 Novel thiazolidinedione derivatives as antidiabetic agents
05/25/2001CA2391913A1 Novel thiazolidinedione derivatives as antidiabetic agents
05/23/2001EP1101770A1 Derivatives of 12,13-(pyranosyl)-indolo(2,3-a)pyrrolo(3,4-c)carbazole and 12,13-(pyranosyl)-furo(3,4-c)indolo(2,3-a)carbazole, their process of preparation and pharmaceutical compositions containing them
05/23/2001EP1100513A1 Autoinducer synthase modulating compounds and uses therefor
05/23/2001EP1100512A2 Preparation of thioarabinofuranosyl compounds and use thereof
05/23/2001CN1296491A 2-(purin-9-YL)-tetrahydrofuran-3, 4-diol derivatives
05/23/2001CN1296011A Purine L-nucleoside, its analogue and use thereof
05/22/2001US6235887 Measurement, calibration of oligonucleotide binding to nucleic acids
05/22/2001US6235266 Dinucleotides useful for the treatment of lung disease
05/22/2001CA2013380C Selective adenosine receptor agents
05/17/2001WO2001034622A1 Combinatorial library synthesis and pharmaceutically active compounds produced thereby
05/17/2001WO2001034619A1 2-aminopurine derivatives
05/17/2001WO2001034618A2 Synthesis of 2'-deoxy-l-nucleosides